ALA
Arovella Therapeutics Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-01-24. The firm is focused on developing therapies to treat human disease. The firm focuses two focus areas are oncology and conditions that impact the central nervous system. The Company’s technology includes iNKT Cell Therapy, DKK1-CAR-iNKT, AR19-iNKT + CF33-CD19, Anagrelide and ZolpiMist. The Company’s invariant natural killer T (iNKT) cell therapy pipeline through the license to the DKK1 monoclonal antibody (mAb). The company develops the DKK1 mAb as a chimeric antigen receptor to use in combination with its iNKT cell therapy platform. The firm is developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. Anagrelide is for the treatment of metastatic disease granted in the United States, Europe, Japan and Australia. ZolpiMist is an oral spray of zolpidem tartrate to treat short- term insomnia.
📈 Performance
Price History
+179.00%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.05
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in ALA
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in ALA
731 days
ALA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
20%
100k - 150k
40%
50k - 100k
40%
Less than 50k
👶 Age of investors
18 - 25
26 - 34
80%
35 - 90
20%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in ALA also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax
📊 Share price
$73.26 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL EX AUSTRALIA
88 Energy Ltd. is an oil and gas exploration company, which is engaged in the exploration and development of mineral properties. The company is headquartered in Subiaco, Western Australia and currently employs 10 full-time employees. The company went IPO on 2000-01-20. The firm is focused on oil exploration and appraisal activities across approximately 440,000 net acres in the Alaskan Central North Slope and NPR-A regions. The firm has a diversified portfolio of four prospective project areas: Project Icewine, Yukon Leases, Project Peregrine and the Umiat oil field. The Project Peregrine covers an area of approximately 195,973 acres. The Umiat Oil Field is located immediately adjacent to Project Peregrine. The Project Icewine is situated on the Central North Slope, Alaska and covers an area of approximately 193,000 acres. The Project Longhorn covers an area of approximately 1,300 net acres in West Andrews and Ector Countries in the Permian Basin.
📊 Share price
$0.01 AUD
Want more shares? Try these...
